New CEO of the Novo Nordisk Foundation

Mads Krogsgaard Thomsen, CSO at Novo Nordisk, will take up the position as CEO of the Novo Nordisk Foundation effective from 1 March 2021.

Read more
© NIAID

Biomarker identifies high-risk COVID-19 patients

Austrian researchers have found that a lack of activation of the NK receptor is highly associated with severe COVID-19 disease courses.

Read more

Management changes at Abliva

Lund-based Abliva AB named Dr Ellen Donnelly as its new CEO. At the beginning of February she succeeded Dr Erik Kinnmann, who had been CEO since 2018.

Read more
© Minaris

MaxiVAX and Minaris Regenerative Medicine ink contract

Swiss cancer vaccine specialist MaxiVAX SA has hired Minaris Regenerative Medicine GmbH to produce its cell therapy MVX-ONCO-2.

Read more
© pearson0612/Pixabay.com

EU orders additional COVID-19 vaccine doses

Pfizer Inc. and BioNTech SE have signed an agreement with the European Commission (EC) to supply an additional 200 million doses of BNT162b2 to the EU.

Read more
Treated liver tumor under the microscope. While the tumor cells (upper part) are strongly affected by the lipotoxic therapy (formation of characteristic lipid droplets and cell death), normal liver cells (lower part) are only barely affected by the therapy. © Daniel Dauch, University Hospital Tübingen

Novel strategy targets chronic liver diseases

A resesarch team headed by HepaRegeneriX Board Member Lars Zender has presented a new approach to treat hepatocellular carcinoma (HCC) by disturbing the lipid metabolism of tumour cells. 

Read more

Swedish AlzeCure appoints CMO

Märta Segerdahl will take over the position as Chief Medical Officer of Swedish AlzeCure Pharma AB on April.

Read more
Colorized scanning electron micrograph of a natural killer cell from a human donor. © NIAID

Cellectis and Cytovia in US$760m licence deal

Cell therapy specialist Cytovia Therapeutics Inc and genome editing expert Cellectis SAS partner to develop iPSC-derived natural killer (NK) cell-based cancer therapies.
 

Read more
Prof. Clemens von Schacky, CEO Omegametrix (©picture: Omegametrix GmbH)

Higher omega-3 level apparently protects from dying from COVID-19

The association of a low HS-Omega-3 Index® and mortality from COVID-19 is analyzed in a comprehensive study with Munich hospital.
Read more
Cellink management team at its headquarters in Boston. The company has been founded and in listed in Stockholm, Sweden. © Cellink AB

Cellink AB acquires Ginolis Oy for €70m

Cellink AB will take over all shares of Ginolis Oy, a Finnish company focusing on diagnostics automation and advanced robotics solutions for medical and diagnostic industries.

Read more